BioClinica Stock

BioClinica provides integrated, technology-enhanced clinical trial management solutions.

Sign up today and learn more about BioClinica Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About BioClinica Stock

BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With more than 20 years of experience and over 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia.

Funding History

June 2009$5.0M
July 2011$8.7M


Executive Vice President of Corporate Development & Strategy

Maria Kraus

Executive Vice President & Chief Financial Officer

David Peters

Chief Executive Officer

John Hubbard

Executive Vice President & President of Medical Imaging & Cardiac Safety

David S Herron

Executive Vice President & President of Clinical Research

Elizabeth Thiele

President of eHealth Solutions

Mukhtar Ahmed

Executive Vice President of Human Resources

Carmella Griffin

Chief Science Officer

Thomas Fuerst

Chief Operating Officer

Nayan Nanavati

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: